Miller & Martin Represents Mayne Pharma Group in Acquisition of Metrics, Inc.
Mayne Pharma Group Limited, a publicly held company based in Melbourne, Australia, announced Thursday, November 15, 2012 that it has completed the acquisition of Metrics, Inc., a North Carolina based pharmaceuticals company, for $105 million paid at closing and an earnout of up to $15 million. Miller & Martin PLLC served as counsel to Mayne Pharma. Miller & Martin was introduced to Mayne Pharma by the prominent Australian law firm Minter Ellison, which is a member of the World Law Group. The World Law Group is a network of 52 leading independent law firms with more than 315 offices in 65 countries, including Miller & Martin for the Southeastern U.S. The acquisition was announced on October 4, 2012. To read the press release announcing the acquisition, please click here.
Metrics, Inc., founded in 1994, is a full-service contract development and manufacturing organization specializing in oral dosage forms. Mayne Pharma Group Limited, founded in 1845, develops and manufacturers oral pharmaceuticals. The company produces branded generics, specialty generics, and active pharmaceutical ingredients.
The Miller & Martin team that represented Mayne Pharma was led by Joe DeLisle in the Atlanta office. Other attorneys involved in the matter include Tom Harrold, Jim Tramonte, Bruce McCall, Mike Marshall, Kent Antley, Bobby Dann, Ashley Halfman, Chris Henderson, Luke Curtis, Jimmy Daniel, Billy Eiselstein, Charles Forlidas and Clay Walts.